Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.06B | 1.08B | 947.85M | 983.11M | 839.99M |
Gross Profit | 314.44M | 311.94M | 260.99M | 261.92M | 268.94M |
EBITDA | 7.03M | 34.97M | 20.71M | 28.77M | 81.85M |
Net Income | -19.93M | 6.21M | 4.49M | 14.02M | 65.82M |
Balance Sheet | |||||
Total Assets | 875.45M | 773.33M | 789.36M | 717.96M | 665.11M |
Cash, Cash Equivalents and Short-Term Investments | 61.32M | 38.18M | 90.50M | 17.93M | 77.17M |
Total Debt | 267.62M | 230.80M | 243.87M | 197.72M | 182.46M |
Total Liabilities | 661.17M | 541.50M | 567.71M | 485.50M | 438.40M |
Stockholders Equity | 214.28M | 231.79M | 221.65M | 232.46M | 226.71M |
Cash Flow | |||||
Free Cash Flow | 19.37M | 4.84M | 18.71M | -3.62M | 12.18M |
Operating Cash Flow | 88.80M | 42.89M | 58.60M | 54.30M | 110.97M |
Investing Cash Flow | -92.83M | -60.86M | -8.34M | -83.36M | -116.84M |
Financing Cash Flow | 22.89M | -32.58M | 26.67M | -32.72M | 68.21M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | HK$574.62M | 4.95 | 20.67% | 10.19% | 25.95% | 44.16% | |
74 Outperform | $945.36M | 9.80 | 2.51% | 8.33% | -1.70% | 12.53% | |
59 Neutral | HK$16.83B | 4.60 | -5.52% | 4.39% | -3.57% | -61.41% | |
56 Neutral | HK$672.76M | ― | -8.95% | ― | -3.09% | -480.17% | |
52 Neutral | HK$418.81M | ― | -6.09% | ― | -30.21% | -12.78% | |
48 Neutral | HK$763.30M | 55.38 | -1.16% | 7.63% | 2.49% | -171.78% | |
43 Neutral | HK$154.00M | ― | -11.66% | ― | -31.49% | 28.61% |
SANVO Fine Chemicals Group Limited has issued a supplemental announcement to its 2024 Annual Report, providing additional details about its Share Schemes. The company disclosed that 209,740 Award Shares were vested in November 2024 under the 2023 Share Award Scheme without any purchase price. The announcement also highlighted the availability of 41,122,283 share options and share awards for grant and 56,490,023 shares available for issue, representing 12.01% of the total ordinary shares in issue.
SANVO Fine Chemicals Group Limited held its Annual General Meeting on June 20, 2025, where all proposed resolutions were unanimously passed. These resolutions included the adoption of financial statements, re-election of directors, and granting mandates for share issuance and repurchase, reflecting strong shareholder support and stable governance.